SUMMARY Patients receiving midazolam, temazepam or zopiclone by mouth as premedication for minor gynaecological surgery were pretreated with either ranitidine or an inert tablet. Pretreatment with ranitidine was associated with a greater degree of drowsiness at 20 and 40 min after midazolam, and a shorter mean time to peak hypnotic effect than in the non-pretreated group. Ranitidine did not affect the degree of drowsiness in the patients receiving temazepam or zopiclone.
importance both in the context of preanaesthetic medication and in patients regularly taking H,-receptor blockers. The present study was designed to evaluate the effects of pretreatment with ranitidine on the clinical effects of the two benzodiazepines, midazolam and temazepam, when given as oral premedication. A third agent, zopiclone, was also studied, as it may become a clinically useful premedicant (Elwood, Dundee et al., 1983) .
PATIENTS AND METHODS
Subjects were adult women, aged between 15 and 50 yr, scheduled for minor gynaecological surgery excluding termination of pregnancy. Their weights ranged from 45 to 80 kg and they conformed to Physical Status grades 1 or 2 of the American Society of Anesthesiologists Classification. None was taking any regular benzodiazepine or enzymeinducing medication. Informed consent was obtained from all patients and all operations were performed in one surgical unit at approximately the same time of day. The study was "doubleblind" in that neither patients nor observers knew the medication given before operation.
At 22.00 h on the evening before surgery and again at 07.00 h on the morning of surgery, patients received either ranitidine 150 mg or an inert tablet; 90 min before operation they received midazolam 10 mg, temazepam 20 mg or zopiclone 7.5 mg orally.
The effects of the drugs were evaluated at 20,40, 60 and 90 min after administration, when the degree of drowsiness and anxiety were quantified according to the method first described by Dundee, Moore and Nicholl (1962) , and used in later studies (Morrison, Clarke and Dundee, 1970; Dundee, Clarke and Howard, 1974) . All observations were made by one of the same three individuals.
An analysis at this stage showed no effect of pretreatment with ranitidine in the temazepam and zopiclone series. However, there was a significantly shorter mean time to peak effect in those patients given ranitidine-midazolam as compared with the controls, and an increase in the degree of drowsiness in the former. The number of patients in each of the midazolam series was BRITISH JOURNAL OF ANAESTHESIA then increased to 32 (Dundee et al., 1985) , at which stage the study had to stop because of a change in staff. The preoperative effects of midazolam did not differ in the additional patients from those in the equivalent initial group, and the findings are pooled for statistical analysis.
RESULTS
Patient groups were broadly comparable with regard to age and weight (table I) . No adverse effects were noted with any of the combinations. Since each was found to have a similar anxiolytic effect, analysis of the results was based on the assessment of drowsiness on a four-point scale: good, fair, slight or nil. Table II shows the degree of drowsiness in each combination 20 and 40 min after administration. Ranitidine did not affect the degree of drowsiness in the patients receiving temazepam and zopiclone. However, with midazolam, pretreatment with ranitidine was clearly associated with a greater degree of drowsiness at 20 and 40 min. At 20 min the number of patients in the "good or fair" categories was significantly higher in the ranitidine-pretreated group, and at 40 min the number of patients in the "slight or no drowsiness" categories was significantly higher in the nonpretreated group (P < 0.025) (Mann-Witney U test). No difference between the ranitidine pretreated and non-pretreated groups was observed at 60 or 90 min with any of the drugs. Table III shows an earlier onset of action of midazolam in those receiving midazolam after ranitidine. The mean time to peak hypnotic effect (t max ) (table IV) of midazolam was shortened significantly by ranitidine. No such effect was noted with temazepam or zopiclone.
DISCUSSION
Ideally, one would like to have increased the number of patients in each series, but money, availability of staff and time did not permit this. The number of patients in the midazolam series was increased because it was only with this drug that any effect of ranitidine could be detected after 40 administrations. The study was tightly controlled in being limited to one hospital unit and a small number of observations, and time was not available to increase the numbers with temazepam or zopiclone.
Several reports indicate that clinical sedation produced by midazolam, assessed both objectively and subjectively, parallels the plasma concentration after i.v. and oral administration (Allonen, Ziegler and Klotz, 1981; Gamble et al., 1981; Kanto et al., 1984) . Increased plasma concentrations of benzodiazepines, associated with pretreatment with Hj-antagonists have been accompanied by increased hypnotic effects when diazepam was given i.v. (Klotz and Reimann, 1980) and orally (McGowan and Dundee, 1982) , and following the oral administration of midazolam (Elwood, Hildebrand et al., 1983) .
The present study confirms that the increased bioavailability of midazolam which follows pre- treatment with ranitidine, and which was found by Elwood, Hildebrand and colleagues (1983) , is sufficient to produce a detectable clinical effect: increased drowsiness 20 and 40 min after administration, although not subsequently. These workers also found evidence of an earlier onset of hypnotic effect of midazolam following ranitidine, and this finding is confirmed here, in that pretreatment with ranitidine was associated with a significantly shorter mean time to peak hypnotic effect of the benzodiazepine. These results are an indication of the necessity to bear in mind that the clinical effects of orally-administered midazolam may be greater, and of more rapid onset, in patients who are taking ranitidine. Possible causes of this have been discussed by Elwood, Hildebrand and colleagues (1983) . This does not appear to apply to temazepam, a finding which is in keeping with our pharmacokinetic findings (Elliott et al., 1984) . Zopiclone also appears to be unaffected by ranitidine.
